Legence - Class A opened lower at $36.38, compared with its previous close of $37.09. In the last trading session, the stock traded between $33.46 and $37.70. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 2 years ago in Legence - Class A is now worth
$ 119.03
Giving a profit of
$ 19.03 (19.03%)
Invest with $1
Note: Past profits do not guarantee future returns.
Revenue rose 85% YoY to a record $1.31 billion, beating analyst estimates of $1.261 billion. Adjusted EBITDA nearly doubled to $177 million, with margins expanding by 100 bps. EPS of $1.15 significantly exceeded the consensus estimate of $0.54. Full-year FY26 revenue guidance raised to $4.87-$4.91 billion; FY27 guidance introduced at $5.3-$5.6 billion. Board authorized a $150 million stock repurchase program.
Today
20Oct
Barclays lowers Legence price target to $60, keeps Equal-Weight
Barclays lowered Legence Corp's price target from $80 to $60. Analyst Adam Seiden maintained an Equal-Weight rating. The price target reduction amounts to a $20 cut.
24 days ago
15Oct
RBC Capital lowers Legence price target to $90, maintains Outperform
RBC Capital lowered Legence Corp's price target to $90 from $101. Analyst Sabahat Khan maintained an Outperform rating on the stock. The price target reduction amounts to $11 per share.
Legence Corp posted Q2 revenue of $1.260 billion, beating the $1.074 billion estimate, but EPS of 17 cents missed the 33-cent consensus. The company raised Q3 sales guidance to $1.225-$1.275 billion. Analysts from BTIG and BMO Capital adjusted price targets, with BTIG lowering its target to $100 and BMO raising theirs to $105.
3mo ago
13Aug
Legence raises FY26 sales guidance to $4.7B-$4.8B range
Legence upgrades FY26 sales guidance to $4.7B-$4.8B, surpassing the $4.274B estimate and its prior $4.1B-$4.3B outlook. The revision reflects stronger revenue expectations, with the new floor exceeding the previous ceiling.
3mo ago
13Aug
Legence Q3 Results: Sales Guidance $1.225B-$1.275B vs $1.08B Est
Legence forecasts Q3 revenue between $1.225 billion and $1.275 billion, beating the $1.080 billion analyst estimate. The guidance implies a significant upside to market expectations, highlighting strong anticipated performance for the quarter.
